Golden
Betalin Therapeutics

Betalin Therapeutics

Betalin Therapeutics is a biological micro-pancreas for insulin-dependent diabetics company founded by Shuki Joshua Hershcovich.

Betalin Therapeutics is developing an Engineered Micro Pancreas (EMP) to improve the quality of life for people with diabetes. The company is headquartered in Ramat Gan, Israel and was founded in 2015 by Shay Hershcovich and Shuki Joshua Hershcovich.



Betalin Therapeutics licensed the EMP technology developed at The Hebrew University of Jerusalem, Israel, in agreement in 2015. The Hebrew University continues to partner with Betalin Therapeutics to support the research and development.







Based on in vitro results and preliminary in vivo results, Betalin Therapeutics submitted a pre-pre-IND (Investigational New Drug) application to the Food and Drug Administration (FDA). Following the FDA's positive response, Betalin Therapeutics is preparing the pre-IND meeting on its way towards IND submission.



Betalin Therapeutics was raising funding in 2018 in order to further optimize the therapy in animal models, complete submission of the IND application to the FDA, and proceed to clinical trials. Betalin Therapeutics was awarded a competitive matching grant from the Office of the Chief Scientist.

Funding

Seed

On January 11, 2017 Betalin Therapeutics completed their seed funding round with €50,000 in funding from the European Union executive agency for SMEs. 

Timeline

January 11, 2017

Seed funding

On January 11, 2017 Betalin Therapeutics completed their seed funding round with €50,000 in funding from the European Union executive agency for SMEs. 

July 2015

Founding of Betalin Therapeutics

Betalin Therapeutics is headquartered in Ramat Gan, Israel and was founded in 2015 by Shay Hershcovich and Shuki Joshua Hershcovich.

People

Name
Role
Related Golden topics

Avi Treves

VP Research and Development



Eli Ishai

Advisory Board Member



Jacob Ben-Aire

CEO



Manuela Vecsler

Senior Scientist



Orit Goldman

Senior Scientist/ Lab manager



Shay Hershcovich

Co-Founder



Shuki Joshua Hershcovich

Co-Founder



Further reading

Title
Author
Link
Type
Date

Betalin Therapeutics Wins Startup Competition at MIXiii Biomed 2017

Betalin Therapeutics

News article



Engineered Micro Pancreas Raises Hope for Type 1 Diabetes Treatment

Patricia Silva

Journal Article



Documentaries, videos and podcasts

Title
Date
Link

Betalin animation

Jan 25, 2016

Betalin information

Feb 26, 2018

Companies

Company
CEO
Location
Products/Services









References